Drug Pipeline

Asciminib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
9
Active Studies
5
Recruiting
2
Phase 3
5
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07039760
Asciminib With or Without Sildenafil for Brain Tumors		 date change Primary completion pushed: 2027-10-31 -> 2028-02-28
2026-06-10 NCT07039760
Asciminib With or Without Sildenafil for Brain Tumors		 date change Completion pushed: 2027-11-30 -> 2028-03-31
2026-05-28 NCT05456191
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib…		 Primary endpoint(s) modified
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-22 NCT07604233 Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML Phase 1/2 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 2
3
Phase 1/2
2
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05456191 A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib… Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Active, Not Recruiting
NCT04971226 A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+… Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Active, Not Recruiting
Phase 2
NCT06368414 A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia Chronic Myeloid Leukemia, Chronic Phase Recruiting
NCT06236724 Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly… Chronic Myeloid Leukemia Recruiting
NCT06629584 Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid… Malignant Solid Tumors Recruiting
Phase 1/2
NCT06308588 Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With… Philadelphia Chromosome-Positive Recruiting
NCT07604233 Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML Myeloid Leukemia Not Yet Recruiting
Phase 1
NCT07250087 Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults… Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Recruiting
Early Phase 1
NCT07039760 Asciminib With or Without Sildenafil for Brain Tumors Brain Tumor Not Yet Recruiting
Sponsors Running Asciminib Trials
M.D. Anderson Cancer Center (4) Novartis Pharmaceuticals (2) Korean Society of Hematology (1) Washington University School of Medicine (1) H. Lee Moffitt Cancer Center and Research Institute (1)
Disease Areas
Leukemia (7) Chronic Myeloid Leukemia (CML) (4) Acute Lymphoblastic Leukemia (ALL) (2)
Get alerts when Asciminib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free